 Mark Roback
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conscious Sedation | 20 | 2021 | 78 | 3.640 |
Why?
| | Emergency Service, Hospital | 30 | 2021 | 1815 | 2.290 |
Why?
| | Ketamine | 17 | 2021 | 92 | 2.000 |
Why?
| | Hypnotics and Sedatives | 12 | 2020 | 133 | 1.790 |
Why?
| | Anesthesia | 3 | 2022 | 117 | 1.430 |
Why?
| | Laryngismus | 3 | 2022 | 6 | 0.940 |
Why?
| | Laryngoscopy | 2 | 2019 | 90 | 0.810 |
Why?
| | Anesthetics, Dissociative | 9 | 2021 | 28 | 0.750 |
Why?
| | Intubation, Intratracheal | 2 | 2019 | 214 | 0.750 |
Why?
| | Analgesia | 5 | 2018 | 82 | 0.720 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 322 | 0.670 |
Why?
| | Airway Management | 1 | 2019 | 59 | 0.600 |
Why?
| | Emergency Medical Services | 3 | 2021 | 581 | 0.580 |
Why?
| | Child, Preschool | 29 | 2021 | 9114 | 0.570 |
Why?
| | Anesthesiology | 1 | 2017 | 35 | 0.570 |
Why?
| | Intubation, Gastrointestinal | 1 | 2017 | 54 | 0.560 |
Why?
| | Child | 38 | 2022 | 18400 | 0.550 |
Why?
| | Gastrostomy | 1 | 2017 | 89 | 0.550 |
Why?
| | Liability, Legal | 1 | 2016 | 38 | 0.520 |
Why?
| | Gastric Bypass | 1 | 2017 | 91 | 0.520 |
Why?
| | Anti-Allergic Agents | 1 | 2016 | 41 | 0.520 |
Why?
| | Fasting | 4 | 2019 | 242 | 0.510 |
Why?
| | Infant | 27 | 2021 | 7943 | 0.500 |
Why?
| | Patient Transfer | 1 | 2016 | 142 | 0.460 |
Why?
| | Hospitalization | 4 | 2017 | 1762 | 0.450 |
Why?
| | Emergency Treatment | 4 | 2021 | 113 | 0.430 |
Why?
| | Hypersensitivity | 1 | 2016 | 252 | 0.420 |
Why?
| | Vomiting | 6 | 2020 | 122 | 0.340 |
Why?
| | Atropine | 2 | 2010 | 25 | 0.320 |
Why?
| | Pediatrics | 5 | 2015 | 982 | 0.320 |
Why?
| | Adolescent | 24 | 2021 | 17800 | 0.310 |
Why?
| | Humans | 52 | 2022 | 114043 | 0.300 |
Why?
| | Midazolam | 4 | 2018 | 43 | 0.270 |
Why?
| | Propofol | 2 | 2017 | 43 | 0.270 |
Why?
| | Anesthetics, Intravenous | 2 | 2017 | 27 | 0.240 |
Why?
| | Male | 28 | 2021 | 55396 | 0.240 |
Why?
| | Premedication | 1 | 2004 | 36 | 0.240 |
Why?
| | Etomidate | 2 | 2016 | 7 | 0.230 |
Why?
| | Bradycardia | 1 | 2004 | 48 | 0.230 |
Why?
| | Consensus | 4 | 2019 | 532 | 0.230 |
Why?
| | Intussusception | 1 | 2003 | 28 | 0.220 |
Why?
| | Orthopedic Procedures | 1 | 2006 | 206 | 0.220 |
Why?
| | Enema | 1 | 2003 | 37 | 0.220 |
Why?
| | Emergency Medicine | 2 | 2004 | 220 | 0.220 |
Why?
| | Prospective Studies | 10 | 2021 | 6195 | 0.210 |
Why?
| | Terminology as Topic | 2 | 2017 | 186 | 0.200 |
Why?
| | Infant, Newborn | 9 | 2021 | 5038 | 0.200 |
Why?
| | Administration, Intravenous | 3 | 2018 | 122 | 0.200 |
Why?
| | Respiratory Tract Diseases | 2 | 2005 | 139 | 0.190 |
Why?
| | Female | 24 | 2021 | 59325 | 0.190 |
Why?
| | Retrospective Studies | 12 | 2021 | 12521 | 0.190 |
Why?
| | Hospitals, Pediatric | 5 | 2021 | 478 | 0.180 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2018 | 87 | 0.180 |
Why?
| | Government Regulation | 1 | 2020 | 46 | 0.180 |
Why?
| | Preoperative Care | 2 | 2020 | 319 | 0.170 |
Why?
| | Epiglottitis | 1 | 2000 | 4 | 0.170 |
Why?
| | Fasciitis, Necrotizing | 1 | 2000 | 9 | 0.170 |
Why?
| | Administration, Intranasal | 2 | 2018 | 75 | 0.170 |
Why?
| | Infant Mortality | 1 | 2000 | 91 | 0.170 |
Why?
| | Racepinephrine | 1 | 2019 | 1 | 0.160 |
Why?
| | Croup | 1 | 2019 | 22 | 0.160 |
Why?
| | Chickenpox | 1 | 2000 | 93 | 0.160 |
Why?
| | Depressive Disorder, Treatment-Resistant | 1 | 2018 | 4 | 0.160 |
Why?
| | Endpoint Determination | 1 | 2018 | 68 | 0.150 |
Why?
| | Oral and Maxillofacial Surgeons | 1 | 2018 | 1 | 0.150 |
Why?
| | Meningococcal Infections | 1 | 1998 | 20 | 0.150 |
Why?
| | Protein C | 1 | 1998 | 43 | 0.150 |
Why?
| | Deep Sedation | 1 | 2017 | 10 | 0.150 |
Why?
| | Respiratory Sounds | 1 | 1998 | 109 | 0.140 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 122 | 0.140 |
Why?
| | Bronchodilator Agents | 1 | 2019 | 239 | 0.140 |
Why?
| | Radiography, Thoracic | 1 | 1998 | 150 | 0.140 |
Why?
| | Reference Standards | 1 | 2017 | 159 | 0.140 |
Why?
| | Comorbidity | 1 | 2021 | 1447 | 0.140 |
Why?
| | Checklist | 1 | 2017 | 84 | 0.140 |
Why?
| | Cohort Studies | 6 | 2020 | 4883 | 0.140 |
Why?
| | Ranitidine | 1 | 2016 | 13 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 519 | 0.130 |
Why?
| | Diphenhydramine | 1 | 2016 | 30 | 0.130 |
Why?
| | Advisory Committees | 1 | 2017 | 207 | 0.130 |
Why?
| | Nitrous Oxide | 1 | 2016 | 15 | 0.130 |
Why?
| | Hematocele | 1 | 1996 | 1 | 0.130 |
Why?
| | Splenic Rupture | 1 | 1996 | 3 | 0.130 |
Why?
| | Methylprednisolone | 1 | 2016 | 80 | 0.130 |
Why?
| | Patient Safety | 2 | 2018 | 273 | 0.130 |
Why?
| | Anxiety | 1 | 2022 | 843 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2019 | 735 | 0.130 |
Why?
| | Shock, Septic | 1 | 1998 | 185 | 0.130 |
Why?
| | Scrotum | 1 | 1996 | 23 | 0.130 |
Why?
| | Bronchiolitis | 1 | 1997 | 81 | 0.130 |
Why?
| | Dexmedetomidine | 1 | 2016 | 45 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 1836 | 0.130 |
Why?
| | Research Design | 2 | 2018 | 919 | 0.120 |
Why?
| | Epinephrine | 1 | 2016 | 163 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2019 | 528 | 0.120 |
Why?
| | Edema | 1 | 1996 | 119 | 0.120 |
Why?
| | Risk Factors | 10 | 2021 | 8614 | 0.120 |
Why?
| | Double-Blind Method | 3 | 2016 | 1656 | 0.120 |
Why?
| | Standard of Care | 1 | 2015 | 62 | 0.120 |
Why?
| | Haemophilus influenzae | 1 | 1994 | 48 | 0.120 |
Why?
| | Research | 1 | 2017 | 389 | 0.120 |
Why?
| | Practice Guidelines as Topic | 4 | 2019 | 1381 | 0.120 |
Why?
| | Canada | 4 | 2018 | 320 | 0.120 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 926 | 0.110 |
Why?
| | Blood | 1 | 1994 | 94 | 0.110 |
Why?
| | Child Behavior Disorders | 1 | 2015 | 131 | 0.110 |
Why?
| | Spleen | 1 | 1996 | 485 | 0.110 |
Why?
| | Treatment Outcome | 5 | 2019 | 9049 | 0.110 |
Why?
| | Streptococcus pneumoniae | 1 | 1994 | 133 | 0.110 |
Why?
| | Wounds and Injuries | 1 | 2000 | 674 | 0.100 |
Why?
| | United States | 4 | 2021 | 12137 | 0.100 |
Why?
| | Wounds, Nonpenetrating | 1 | 1996 | 249 | 0.100 |
Why?
| | Bacteremia | 1 | 1994 | 160 | 0.100 |
Why?
| | Patient-Centered Care | 1 | 2017 | 470 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 771 | 0.100 |
Why?
| | Oxygen | 1 | 1997 | 851 | 0.100 |
Why?
| | Analgesics | 2 | 2005 | 156 | 0.100 |
Why?
| | Patient Readmission | 1 | 1997 | 607 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2764 | 0.100 |
Why?
| | Incidence | 7 | 2017 | 2314 | 0.090 |
Why?
| | Infusions, Intravenous | 3 | 2009 | 370 | 0.090 |
Why?
| | Patient Discharge | 1 | 1997 | 770 | 0.090 |
Why?
| | Adult | 6 | 2019 | 30375 | 0.090 |
Why?
| | Clinical Protocols | 2 | 2015 | 232 | 0.090 |
Why?
| | Anesthesia Recovery Period | 2 | 2009 | 9 | 0.090 |
Why?
| | Quality Improvement | 1 | 2017 | 944 | 0.090 |
Why?
| | Glycopyrrolate | 1 | 2010 | 2 | 0.090 |
Why?
| | Adjuvants, Anesthesia | 1 | 2010 | 8 | 0.090 |
Why?
| | Muscarinic Antagonists | 1 | 2010 | 25 | 0.080 |
Why?
| | Injections, Intramuscular | 2 | 2009 | 117 | 0.080 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2009 | 13 | 0.080 |
Why?
| | Neck Pain | 1 | 2009 | 24 | 0.080 |
Why?
| | Fentanyl | 2 | 2012 | 67 | 0.080 |
Why?
| | Neck Injuries | 1 | 2009 | 17 | 0.080 |
Why?
| | Time Factors | 4 | 2020 | 6077 | 0.080 |
Why?
| | Diabetic Ketoacidosis | 2 | 2002 | 161 | 0.080 |
Why?
| | Psychomotor Agitation | 1 | 2009 | 65 | 0.080 |
Why?
| | Ondansetron | 1 | 2008 | 8 | 0.080 |
Why?
| | Antiemetics | 1 | 2008 | 32 | 0.070 |
Why?
| | Respiratory System | 1 | 2009 | 137 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2015 | 757 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2017 | 2122 | 0.070 |
Why?
| | Age Factors | 5 | 2021 | 2885 | 0.070 |
Why?
| | Colorado | 3 | 2005 | 4090 | 0.070 |
Why?
| | Foeniculum | 1 | 2005 | 1 | 0.060 |
Why?
| | Plant Poisoning | 1 | 2005 | 9 | 0.060 |
Why?
| | Methemoglobinemia | 1 | 2005 | 13 | 0.060 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 36 | 0.060 |
Why?
| | Guideline Adherence | 2 | 2019 | 489 | 0.060 |
Why?
| | Reflex | 1 | 2004 | 63 | 0.060 |
Why?
| | Chi-Square Distribution | 3 | 2010 | 492 | 0.060 |
Why?
| | Respiration Disorders | 1 | 2004 | 68 | 0.060 |
Why?
| | Logistic Models | 4 | 2016 | 1829 | 0.060 |
Why?
| | Respiratory Aspiration | 2 | 2018 | 31 | 0.050 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 949 | 0.050 |
Why?
| | Hypocapnia | 1 | 2001 | 6 | 0.050 |
Why?
| | Injections, Intravenous | 2 | 2013 | 198 | 0.050 |
Why?
| | Blood Urea Nitrogen | 1 | 2001 | 51 | 0.050 |
Why?
| | Recurrence | 1 | 2003 | 925 | 0.050 |
Why?
| | Brain Edema | 1 | 2001 | 59 | 0.040 |
Why?
| | Infant Equipment | 1 | 2000 | 7 | 0.040 |
Why?
| | Fever | 1 | 2021 | 280 | 0.040 |
Why?
| | Risk Assessment | 3 | 2018 | 2958 | 0.040 |
Why?
| | Respiratory Aspiration of Gastric Contents | 1 | 2019 | 1 | 0.040 |
Why?
| | Corneal Diseases | 1 | 2000 | 32 | 0.040 |
Why?
| | Streptococcus pyogenes | 1 | 2000 | 30 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2020 | 172 | 0.040 |
Why?
| | Case-Control Studies | 3 | 2010 | 3003 | 0.040 |
Why?
| | Eye Injuries | 1 | 2000 | 42 | 0.040 |
Why?
| | Transportation of Patients | 1 | 2000 | 51 | 0.040 |
Why?
| | Length of Stay | 1 | 2003 | 957 | 0.040 |
Why?
| | Delphi Technique | 1 | 2019 | 157 | 0.040 |
Why?
| | Cholinergic Antagonists | 2 | 2009 | 27 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 1791 | 0.040 |
Why?
| | Hypoxia | 1 | 2004 | 956 | 0.040 |
Why?
| | Benzodiazepines | 2 | 2009 | 114 | 0.040 |
Why?
| | American Dental Association | 1 | 2018 | 7 | 0.040 |
Why?
| | Prothrombin | 1 | 1998 | 22 | 0.040 |
Why?
| | Anesthesiologists | 1 | 2018 | 11 | 0.040 |
Why?
| | Survival | 1 | 1998 | 37 | 0.040 |
Why?
| | Platelet Count | 1 | 1998 | 79 | 0.040 |
Why?
| | Radiology, Interventional | 1 | 2018 | 26 | 0.040 |
Why?
| | Acute Disease | 2 | 2002 | 907 | 0.040 |
Why?
| | Hematocrit | 1 | 1998 | 86 | 0.040 |
Why?
| | Resuscitation | 1 | 2000 | 221 | 0.040 |
Why?
| | Triage | 1 | 2000 | 197 | 0.040 |
Why?
| | Hypoglycemia | 1 | 2002 | 386 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2000 | 1690 | 0.040 |
Why?
| | Leukocyte Count | 1 | 1998 | 292 | 0.040 |
Why?
| | Physical Examination | 1 | 2018 | 221 | 0.040 |
Why?
| | Fibrinogen | 1 | 1998 | 143 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2020 | 587 | 0.030 |
Why?
| | Multivariate Analysis | 3 | 2010 | 1422 | 0.030 |
Why?
| | Hospitals, General | 1 | 2016 | 18 | 0.030 |
Why?
| | Endotoxins | 1 | 1998 | 211 | 0.030 |
Why?
| | Rabbits | 1 | 1998 | 733 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2000 | 385 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2018 | 481 | 0.030 |
Why?
| | Diagnostic Errors | 1 | 1997 | 150 | 0.030 |
Why?
| | Hemoglobins | 1 | 1998 | 308 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 1996 | 108 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 655 | 0.030 |
Why?
| | Remission Induction | 1 | 2015 | 233 | 0.030 |
Why?
| | Heart Diseases | 1 | 1998 | 329 | 0.030 |
Why?
| | Thrombosis | 1 | 1998 | 295 | 0.030 |
Why?
| | Spectrophotometry | 1 | 1994 | 47 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 951 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2005 | 1726 | 0.030 |
Why?
| | Heart Arrest | 1 | 2016 | 293 | 0.030 |
Why?
| | Databases, Factual | 1 | 2017 | 1125 | 0.030 |
Why?
| | Algorithms | 1 | 2019 | 1469 | 0.030 |
Why?
| | Young Adult | 2 | 2017 | 10444 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 1996 | 1331 | 0.020 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2010 | 10 | 0.020 |
Why?
| | Switzerland | 1 | 2009 | 17 | 0.020 |
Why?
| | Pain | 1 | 2015 | 701 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2002 | 3254 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 4402 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 1998 | 3498 | 0.020 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2008 | 68 | 0.020 |
Why?
| | Registries | 1 | 2015 | 1764 | 0.020 |
Why?
| | Fractures, Bone | 1 | 2012 | 367 | 0.020 |
Why?
| | Documentation | 1 | 2008 | 166 | 0.020 |
Why?
| | Contraindications | 1 | 2006 | 84 | 0.020 |
Why?
| | Methylene Blue | 1 | 2005 | 22 | 0.020 |
Why?
| | Cyanosis | 1 | 2005 | 15 | 0.020 |
Why?
| | Foodborne Diseases | 1 | 2005 | 44 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 743 | 0.010 |
Why?
| | Bicarbonates | 1 | 2001 | 41 | 0.010 |
Why?
| | Random Allocation | 1 | 2001 | 328 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2000 | 302 | 0.010 |
Why?
| | Fluorescein Angiography | 1 | 2000 | 104 | 0.010 |
Why?
| | Drug Interactions | 1 | 2000 | 337 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2001 | 218 | 0.010 |
Why?
| | Reference Values | 1 | 2000 | 739 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2002 | 1080 | 0.010 |
Why?
| | Visual Acuity | 1 | 2000 | 272 | 0.010 |
Why?
| | Sex Factors | 1 | 2002 | 1706 | 0.010 |
Why?
| | Animals | 1 | 1998 | 31565 | 0.010 |
Why?
| | Mental Disorders | 1 | 2002 | 889 | 0.010 |
Why?
|
|
Roback's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|